
Menezes Remedies Limited
About Menezes Remedies Limited
Data last updated:
Menezes Remedies Limited is a public limited company based in Panjim, Goa, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 February 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U52311GA1996PLC002041. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Brenda Juliette Nazareth Menezes and Maryann Veronica Menezes.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5th Floor Dempo Towers Edc Patto Plaza, Panjim, Goa, India – 403001.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.69 Cr, a growth of 73% compared to the previous year. For the same year it recorded a net profit of ₹3.94 Cr (net margin 22.3%) and EBITDA of ₹5.16 Cr (EBITDA margin 29.2%). Revenue has grown at a compounded annual rate (CAGR) of 443% over three years and 151% over five years.
Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹95 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Menezes Remedies Limited's registered office is in Panjim, Goa. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address5th Floor Dempo Towers Edc Patto Plaza, Panjim, Goa, India – 403001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Menezes Remedies Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Menezes Remedies Limited
FY 2025 filings availableMenezes Remedies Limited reported revenue of ₹17.69 Cr (up 73% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 151% over five years, including 73% growth in the latest year. EBITDA rose 127% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.94 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.2% | ||||
| Net Profit Margin | 22.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Menezes Remedies Limited, buy the company report.
Board of directors of Menezes Remedies Limited
Menezes Remedies has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brenda Juliette Nazareth Menezes Also directs: Menezes Pharmaceuticals Limited, CFL Pharmaceuticals Limited, Frederick Electro Devices Private Limited and 2 more | Director | 09 Jan 2017 | 9 Years 10 Months | Current |
| Maryann Veronica Menezes Also directs: Menezes Pharmaceuticals Limited, CFL Pharmaceuticals Limited, Frederick Electro Devices Private Limited and 2 more | Director | 31 Aug 2012 | 14 Years 2 Months | Current |
| Christine Stephanie Menezes Also directs: Menezes Pharmaceuticals Limited, CFL Pharmaceuticals Limited, Frederick Electro Devices Private Limited and 2 more | Director | 09 Jan 2017 | 9 Years 10 Months | Current |
| Peter Mark Menezes Also directs: Menezes Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 1 more | Additional Director | 18 Dec 2025 | 0 Years 11 Months | Current |
Peer comparison
Menezes Remedies Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Supertechnique Structurals & Projects (India)Private Limited | ₹17.89 Cr (FY 2025) | 51.0% | Hyerabad, Telangana, India | |||
| Naxcuure Healthcare Private Limited | ₹17.88 Cr (FY 2025) | -27.0% | Mehsana, Gujarat, India | |||
| Kkiran P3 International Private Limited | ₹17.83 Cr (FY 2024) | -24.0% | Nahan, Himachal Pradesh, India | |||
| Umang Pharmatech Pvt Ltd | ₹17.8 Cr (FY 2025) | -31.0% | Vasai, Maharashtra, India | |||
| R'keon Life Sciences Private Limited | ₹17.7 Cr (FY 2024) | -10.0% | Allahabad, Uttar Pradesh, India | |||
| Menezes Remedies Limitedthis company | ₹17.69 Cr (FY 2025) | ₹3.94 Cr | 22.3% | 73.0% | Panjim, Goa, India | |
| Semler Research Center Private Limited | ₹17.66 Cr (FY 2025) | 926.0% | Bengaluru, Karnataka, India | |||
| Aarsh Remedies Private Limited | ₹17.64 Cr (FY 2025) | 34.0% | Ahmedabad, Gujarat, India | |||
| Parker Robinson Pvt Ltd | ₹17.62 Cr (FY 2025) | 5.0% | Kolkata, West Bengal, India | |||
| Nulife Pharmaceuticals Private Limited | ₹17.55 Cr (FY 2024) | 6.0% | Mumbai, Maharashtra, India | |||
| SSS Pharmachem Private Limited | ₹17.51 Cr (FY 2025) | 11.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Menezes Remedies Limited, buy the company report.
Auditor
Menezes Remedies Limited is audited by S R KENKRE & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R KENKRE & ASSOCIATES | FY 2019 | 104978W |
Shareholding
The shareholding of Menezes Remedies Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Menezes Remedies Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jan 2004 | 90077572 | Corporation Bank | ₹95 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Menezes Remedies Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Mumbai | Court case (MA(CompaniesAct)) | Filed against the company by an individual | Disposed |
To see the full case history of Menezes Remedies Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Menezes Remedies Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Menezes Remedies has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Menezes Pharmaceuticals Limited | U24232GA1996PLC002040 |
To see the full group structure of Menezes Remedies Limited, buy the company report.
GST
Menezes Remedies has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Menezes Remedies Limited, buy the company report.
Recent activity
Menezes Remedies Limited has 12 board changes on record since 1999: 8 appointments and 4 cessations. The latest: Peter Mark Menezes was appointed as Additional Director on 18 Dec 2025.
4 earlier events are in the company report.
Frequently asked questions
Menezes Remedies is an active public limited company based in Panjim, Goa, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 February 1996 (30+ years old) and is registered under CIN U52311GA1996PLC002041.
Menezes Remedies has 4 current directors:
- Brenda Juliette Nazareth Menezes - Director
- Maryann Veronica Menezes - Director
- Christine Stephanie Menezes - Director
- Peter Mark Menezes - Additional Director
The latest financial statements of Menezes Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Menezes Remedies has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Menezes Remedies is U52311GA1996PLC002041. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Menezes Remedies has 1 court case on record: 1 filed against it.
Menezes Remedies was incorporated on 16 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Goa.
The peers of Menezes Remedies by revenue are Supertechnique Structurals & Projects (India)Private Limited, Naxcuure Healthcare Private Limited, Kkiran P3 International Private Limited, Umang Pharmatech Pvt Ltd, R'keon Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Peter Mark Menezes was appointed as Additional Director on 18 Dec 2025. Brenda Juliette Nazareth Menezes was appointed as Director on 09 Jan 2017. Christine Stephanie Menezes was appointed as Director on 09 Jan 2017. Menezes Remedies has 12 board changes on record in total.
The registered office of Menezes Remedies is at 5th Floor Dempo Towers Edc Patto Plaza, Panjim, Goa, India – 403001.
Menezes Remedies operates in the pharma industry, in the drug formulation and development segment.

